How GLP-1 medications support meaningful, sustainable weight loss. Learn what realistic results look like, what to expect over time, and how to maximize progress and maintain it for the long term.
Weight Loss
A new study reveals a troubling paradox: people who successfully lose weight using Ozempic are judged more harshly than people who don't lose weight at all. The findings highlight deep-seated biases about "earned" weight loss that GLP-1 patients face daily. Understanding this stigma can help you prepare, advocate for yourself, and stay focused on your health goals.
Bariatric surgeons across the country are watching GLP-1 medications change the weight loss landscape. This article breaks down how drugs like semaglutide and tirzepatide fit alongside surgical options, what the evidence says, and how to decide which path is right for you.
Medicare is moving toward covering GLP-1 medications for weight loss, which could dramatically lower costs for millions of older Americans. This guide explains who qualifies, when coverage kicks in, and what steps to take now. If you're on Medicare and considering semaglutide or tirzepatide, this is essential reading.
Emerging research suggests that semaglutide, the active ingredient in Ozempic, may be associated with lower rates of depression and anxiety. This adds a new layer to how doctors and patients think about GLP-1 medications beyond weight loss. Here's what the science says and what it means for you.
Research confirms what many GLP-1 users already feel — that losing weight with medication invites more criticism than losing it "the old-fashioned way." Understanding why this happens can help you protect your mental health and stay on track with your treatment.
GLP-1 weight loss progress from month 1 through month 12.
How GLP-1s produce 15 to 22% body weight loss and what to expect.
What makes Zepbound different from Mounjaro and why it matters.
%20(1).avif)
%20(1).avif)
.avif)